Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Guillemin

Showing results (11-20 of 336) with videos related to

Pageof 34
Sort By:
AARN News Letter|January 1, 1986
The University of Calgary outreach post R.N. degree program: a demonstration projectE J Guillemin
La Psychiatrie De L'Enfant|January 1, 1987
[Microprocesses in early dialogue. Strategies of autonomy]E Fivaz, J Guillemin
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|December 20, 1970
[Illness and death of Alexis I Comnenus]A Rubens-Duval, J Guillemin
International Journal of Tryptophan Research : IJTR|November 16, 2011
Kynurenine pathway metabolites in humans: disease and healthy StatesYiquan Chen, Gilles J Guillemin
Redox Report : Communications in Free Radical Research|October 25, 2002
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's diseaseGilles J Guillemin, Bruce J Brew
Journal of Leukocyte Biology|November 13, 2003
Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identificationGilles J Guillemin, Bruce J Brew
Journal of Speech and Hearing Research|June 1, 1984
Microprocessor-based speech processing systemB J Guillemin, D T Nguyen
Neurotoxicity Research|August 5, 2019
The Cyanotoxin and Non-protein Amino Acid β-Methylamino-L-Alanine (L-BMAA) in the Food Chain: Incorporation into Proteins and Its Impact on Human HealthRachael A Dunlop, Gilles J Guillemin
Frontiers in Aging Neuroscience|August 8, 2014
The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosisDavid B Lovejoy, Gilles J Guillemin
Frontiers in Neuroscience|October 17, 2019
Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral SclerosisVanessa X Tan, Gilles J Guillemin
Pageof 34

Showing results (11-20 of 336) with videos related to

Sort By:
Pageof 34
AARN News Letter|January 1, 1986
The University of Calgary outreach post R.N. degree program: a demonstration projectE J Guillemin
La Psychiatrie De L'Enfant|January 1, 1987
[Microprocesses in early dialogue. Strategies of autonomy]E Fivaz, J Guillemin
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|December 20, 1970
[Illness and death of Alexis I Comnenus]A Rubens-Duval, J Guillemin
International Journal of Tryptophan Research : IJTR|November 16, 2011
Kynurenine pathway metabolites in humans: disease and healthy StatesYiquan Chen, Gilles J Guillemin
Redox Report : Communications in Free Radical Research|October 25, 2002
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's diseaseGilles J Guillemin, Bruce J Brew
Journal of Leukocyte Biology|November 13, 2003
Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identificationGilles J Guillemin, Bruce J Brew
Journal of Speech and Hearing Research|June 1, 1984
Microprocessor-based speech processing systemB J Guillemin, D T Nguyen
Neurotoxicity Research|August 5, 2019
The Cyanotoxin and Non-protein Amino Acid β-Methylamino-L-Alanine (L-BMAA) in the Food Chain: Incorporation into Proteins and Its Impact on Human HealthRachael A Dunlop, Gilles J Guillemin
Frontiers in Aging Neuroscience|August 8, 2014
The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosisDavid B Lovejoy, Gilles J Guillemin
Frontiers in Neuroscience|October 17, 2019
Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral SclerosisVanessa X Tan, Gilles J Guillemin
Pageof 34